Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Oritavancin for the treatment of complicated gram-positive infection in persons who inject drugs.

  • Authors : Ahiskali A; Department of Pharmacy, Hennepin Healthcare, 701 Park Avenue, Minneapolis, MN, 55415, USA.; Rhodes H

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Gram-Positive Bacterial Infections/Gram-Positive Bacterial Infections/Gram-Positive Bacterial Infections/*drug therapy ; Lipoglycopeptides/Lipoglycopeptides/Lipoglycopeptides/*therapeutic use

  • Source: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2020 Oct 28; Vol. 21 (1), pp. 73. Date of Electronic Publication: 2020 Oct 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Oritavancin polymethylmethacrylate (PMMA)-compressive strength testing and in vitro elution.

  • Authors : Schmidt-Malan SM; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.; Greenwood-Quaintance KE

Subjects: Polymethyl Methacrylate*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Lipoglycopeptides/Lipoglycopeptides/Lipoglycopeptides/*administration & dosage

  • Source: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2019 Feb 12; Vol. 14 (1), pp. 43. Date of Electronic Publication: 2019 Feb 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.

  • Authors : Stryjewski ME; Department of Medicine, Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clinicas (CEMIC) 'Norberto Quirno', Av, Las Heras 2981, Office #3, Capital Federal (C1425ASG), Buenos Aires, Argentina. .; Lentnek A

Subjects: Aminoglycosides/Aminoglycosides/Aminoglycosides/*therapeutic use ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Bacteremia/Bacteremia/Bacteremia/*drug therapy

  • Source: BMC infectious diseases [BMC Infect Dis] 2014 May 23; Vol. 14, pp. 289. Date of Electronic Publication: 2014 May 23.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-3 of  3 results for ""Lipoglycopeptides""